Literature DB >> 30816631

SEAM-PsA: Seems Like Methotrexate Works in Psoriatic Arthritis?

Joseph F Merola1, Alexis Ogdie2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30816631      PMCID： PMC6776993          DOI： 10.1002/art.40872

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  25 in total

1.  Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?

Authors:  Philip J Mease
Journal:  Nat Rev Rheumatol       Date:  2012-05-02       Impact factor: 20.543

2.  Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.

Authors:  Sandra L Goss; Cheri E Klein; Ziyi Jin; Charles S Locke; Ramona C Rodila; Hartmut Kupper; Gerd-Rudiger Burmester; Walid M Awni
Journal:  Clin Ther       Date:  2018-02       Impact factor: 3.393

Review 3.  Recognizing and managing comorbidities in psoriatic arthritis.

Authors:  Alexis Ogdie; Sergio Schwartzman; M Elaine Husni
Journal:  Curr Opin Rheumatol       Date:  2015-03       Impact factor: 5.006

Review 4.  Tumor necrosis factor inhibitors in psoriatic arthritis.

Authors:  Santhi Mantravadi; Alexis Ogdie; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2017-05-22       Impact factor: 5.045

5.  Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis.

Authors:  R F Willkens; H J Williams; J R Ward; M J Egger; J C Reading; P J Clements; E S Cathcart; C O Samuelson; M A Solsky; S B Kaplan
Journal:  Arthritis Rheum       Date:  1984-04

6.  Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials.

Authors:  Bernard Combe; Frank Behrens; Neil McHugh; Fiona Brock; Urs Kerkmann; Blerina Kola; Gaia Gallo
Journal:  J Rheumatol       Date:  2016-05-01       Impact factor: 4.666

7.  Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.

Authors:  F Cantini; L Niccoli; C Nannini; E Cassarà; P Pasquetti; I Olivieri; C Salvarani
Journal:  Rheumatology (Oxford)       Date:  2008-04-09       Impact factor: 7.580

8.  Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study.

Authors:  Laura C Coates; Philip S Helliwell
Journal:  J Rheumatol       Date:  2015-12-15       Impact factor: 4.666

9.  Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.

Authors:  Elisabeth Lie; Désirée van der Heijde; Till Uhlig; Marte S Heiberg; Wenche Koldingsnes; Erik Rødevand; Cecilie Kaufmann; Knut Mikkelsen; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2009-09-09       Impact factor: 19.103

10.  Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort.

Authors:  Vinod Chandran; Catherine T Schentag; Dafna D Gladman
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666
View more
  1 in total

1.  Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination.

Authors:  Vibeke Strand; Philip J Mease; Ervant J Maksabedian Hernandez; Bradley S Stolshek; Lyrica X H Liu; David H Collier; Gregory Kricorian; Joseph F Merola
Journal:  RMD Open       Date:  2021-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.